{"url_path":"/sec/ach/8-k/2026-05-15/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 ****Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/75252/0001104659-26-061888-index.html","accession_number":"0001104659-26-061888","cik":"0000075252","ticker":"ACH","issuer_name":"ACCENDRA HEALTH INC/VA/","edgar_url":"https://www.sec.gov/Archives/edgar/data/75252/0001104659-26-061888-index.html","primary_entity_key":"0000075252","primary_entity_name":"ACCENDRA HEALTH INC/VA/"},"word_count":170,"has_tables":true,"body_markdown":"**Item 5.02****Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\nOn May 14, 2026 at the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Accendra Health, Inc. (the “Company”), the shareholders approved the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan (the “Amended and Restated 2023 Plan”) which amends and restates the Owens & Minor, Inc. 2023 Omnibus Incentive Plan (as amended as of March 14, 2024). The description of the Amended and Restated 2023 Plan included in the Company's proxy statement filed with the Securities and Exchange Commission on April 2, 2026 is incorporated herein by reference.\n\nUnder the terms of the Amended and Restated 2023 Plan, the Board of Directors (the “Board”) has authorized the Our People & Culture Committee of the Board to grant equity and other incentive awards to employees, non-employee directors and consultants. Each equity grant made pursuant thereto will be evidenced by an agreement between the Company and the person named therein."}